FDA to Finally Ban Controversial Ingredient in Popular Decongestants
Sudafed, Mucinex, Benadryl, Advil, Tylenol, Vicks, and Dimetapp. These popular brand names appear on oral decongestants that are staples of the cold and flu aisle in American drug stores, and yet many contain an ingredient that does not work as promised.
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter decongestants – from the market, citing evidence that it doesn’t work.
Which Decongestants Are Effective? Why the FDA Wants to Pull a Popular Medicine Ingredient
Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its job at "unstuffing" when taken by mouth.
Popular cold medicine ingredient deemed ineffective | Today in Pa.
Feel free to subscribe, follow or rate “Today in Pa.” as you see fit! The FDA is looking to pull a common ingredient used in popular cold medicines from the market. Pennsylvania’s population grew last year.
A Popular Decongestant Doesn’t Work. The FDA Is Finally Doing Something About It
Oral phenylephrine was shown to be ineffective for treating nasal congestion over a year go. This week, the FDA took the first steps toward removing it from pharmacy shelves.
FDA issue order against common ingredient found in cold and flu medicine
The US Food and Drug Administration (FDA) has proposed an order to ban a popular ingredient in cold and flu medicines as it is seemingly not as effective as other methods. Oral phenylephrine is often found in many over-the-counter cold and flu treatments,
FDA proposes to end use of decongestant found in cold meds
The Food and Drug Administration has proposed ending the use of a common ingredient found in many popular over-the-counter cold and allergy medications.
US FDA lifts clinical hold on Novavax's combo COVID-flu shot
The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines after a safety concern was found to be unrelated ...
Trump 2.0 spells uncertainty for US healthcare, says analyst
A GlobalData analyst has warned that Trump's second term could see major changes in US healthcare, and RFK could rock the ...
STAT19h
Risk of aspiration during surgery added to GLP-1 drug labels
To submit a correction request, please visit our Contact Us page. Compounding group sues FDA for removing Lilly’s obesity ...
US FDA approves Johnson & Johnson's device for heart condition
The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...
Yahoo Finance6h
Autolus secures FDA approval for CAR-T cell therapy use in ALL
Autolus Therapeutics has secured US Food and Drug Administration (FDA) approval for Aucatzyl (obecaktagene autoleucel), ...
ENDPOINTS NEWS10h
FDA ap­proves Au­to­lus’ CAR-T cell ther­a­py for ag­gres­sive blood can­cer
US regulators gave the green light to Autolus Therapeutics’ cell therapy for adult B-cell precursor acute lymphoblastic leukemia, or B-ALL, that has returned or is not responding to prior treatment ...
Modern Healthcare15h
To solve drug shortages, fix the broken economic model
Drug shortages in the U.S. are increasing in number and duration, primarily affecting generic and multi-sourced drugs that ...
Medscape3d
Why a Failed Confirmatory Trial May Not Mean a Failed Drug
The US Food and Drug Administration (FDA) sometimes allows cancer drugs with accelerated approvals to remain on the ...
Food10d
FDA limits phthalate ban to nine compounds
The FDA’s recent decision to remove 23 phthalates from food-contact uses while conducting safety assessments on remaining ...
Hosted on MSN3d
Teen drug use is declining in the US overall—here's how rates in California compare to other states
Substance Use Treatment Facilities examined data from SAMHSA and other sources to see how teen drug use varies across the U.S ...